Effectiveness of bortezomib in multiple myeloma: Preliminary results from an international electronic observational study

被引：0
|
作者：
Delforge, M. [1 ]
Katodritou, E. [2 ]
Zervas, K. [2 ]
Sargin, D. [3 ]
Hulin, C. [4 ]
Linderholm, M. [5 ]
Verrou, E. [2 ]
Poon, V [6 ]
Dhawan, R. [6 ]
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] Theagenion Canc Ctr, Thessaloniki, Greece
[3] Istanbul Univ, Istanbul, Turkey
[4] CHU NANCY Brabois, Nancy, France
[5] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[6] Johnson & Johnson Pharmaceut Serv, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70183-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [21] Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study
    Yimer, Habte
    Melear, Jason
    Faber, Edward
    Bensinger, William, I
    Burke, John M.
    Narang, Mohit
    Stevens, Don
    Gray, Kathleen S.
    Lutska, Yana
    Bobba, Padma
    Qi, Keqin
    Hoehn, Daniela
    Qi, Ming
    Lin, Thomas S.
    Rifkin, Robert M.
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2383 - 2392
  • [22] Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
    Chen, Wendong
    Yang, Yicheng
    Chen, Yi
    Du, Fen
    Zhan, Huan
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 137 - 151
  • [23] EFFECTIVENESS OF BORTEZOMIB AND BORTEZOMIB-CONTAINING PROGRAMS FOR THE TREATMENT OF RECURRENT AND RESISTANT MULTIPLE MYELOMA
    Mitina, T. A.
    Golenkov, A. K.
    Katayeva, E. V.
    Lutskaya, T. D.
    Trifonona, E. V.
    Klinushkina, E. F.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (07) : 57 - 61
  • [24] Safety and efficacy results from an international phase 3b study for expanded access to Bortezomib in patients with relapsed and/or refractory multiple myeloma
    Mikhael, J.
    Belch, A.
    Prince, M.
    Lucio, M. Nambo
    Maiolino, A.
    Corso, A.
    Petrucci, M. T.
    Musto, P.
    Komarnicki, M.
    Stewart, A. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 164 - 164
  • [25] Improved Response Rates with Bortezomib in Relapsed or Refractory Multiple Myeloma: An Observational Study in Chinese Patients
    MaoFang Lin
    Jian Hou
    WenMing Chen
    XiaoJun Huang
    ZhuoGang Liu
    YuHong Zhou
    Yan Li
    Taiyun Zhao
    LinNa Wang
    Kwang-Wei Wu
    ZhiXiang Shen
    Advances in Therapy, 2014, 31 : 1082 - 1094
  • [26] Improved Response Rates with Bortezomib in Relapsed or Refractory Multiple Myeloma: An Observational Study in Chinese Patients
    Lin, MaoFang
    Hou, Jian
    Chen, WenMing
    Huang, XiaoJun
    Liu, ZhuoGang
    Zhou, YuHong
    Li, Yan
    Zhao, Taiyun
    Wang, LinNa
    Wu, Kwang-Wei
    Shen, ZhiXiang
    ADVANCES IN THERAPY, 2014, 31 (10) : 1082 - 1094
  • [27] A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma
    Petrucci, Maria T.
    Giraldo, Pilar
    Corradini, Paolo
    Teixeira, Adriana
    Dimopoulos, Meletios A.
    Blau, Igor W.
    Drach, Johannes
    Angermund, Ralf
    Allietta, Nathalie
    Broer, Esther
    Mitchell, Vivien
    Blade, Joan
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) : 649 - 659
  • [28] Infection in multiple myeloma: Preliminary results of a multicenter prospective study
    Nucci, M.
    Garnica, M.
    Maiolino, A.
    de Souza, I. R. G.
    Bittencourt, R.
    Silla, L.
    Trabasso, P.
    de Souza, C. A.
    Hungria, V. T.
    Rabagliata, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 213 - 213
  • [29] BORTEZOMIB-BASED THERAPIES FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-WORLD MEDICAL PRACTICE: FINAL DATA FROM THE INTERNATIONAL, OBSERVATIONAL EVOBS STUDY
    Terpos, E.
    Katodritou, E.
    de la Rubia, J.
    Hungria, V.
    Hulin, C.
    Roussou, M.
    Delforge, M.
    Bries, G.
    Stoppa, A.
    Aagesen, J.
    Sargin, D.
    Belch, A.
    Diels, J.
    Chirita, O.
    Olie, R.
    Robinson, D., Jr.
    Dhawan, R.
    Ganguly, R.
    Potamianou, A.
    van de Velde, H.
    Dimopoulos, M.
    HAEMATOLOGICA, 2013, 98 : 601 - 601
  • [30] Lenalidomide with dexamethasone to multiple myeloma patients relapsing from bortezomib-based induction therapies: A prospective, observational study
    Tan, Tran-Der
    Hong, Ying-Chung
    Li, Sin-Syue
    Yu, Jui-Ting
    Sung, Yung-Chuan
    Wang, Po-Nan
    Teng, Chieh-Lin Jerry
    CHINESE JOURNAL OF PHYSIOLOGY, 2020, 63 (05): : 211 - +
12345